Who’s spending and who’s cutting from Big Pharma’s $127B R&D budget? Here are the top 15 players
A couple of the Big 15 biopharma companies in R&D hit the gas on research spending last year. Merck and Sanofi still have lots to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
